The HELP-PCI trial showed that in patients with STEMI, early administration of unfractionated heparin at first medical contact led to improved culprit artery TIMI flow before PCI but did not reduce ...

The U.S. Food and Drug Administration (FDA) announced on April 15 that Abbott/Thoratec Corp. is recalling the Heartmate II and Heartmate 3 Left Ventricular Assist System (LVAS) due to long-term ...

Introduction and Scope of the Problem The incidence of venous thromboembolism (VTE), including pulmonary embolism (PE) and deep venous thromboembolism (DVT), in the United States is unclear because ...

Cardiology asked Fry, members of the Task Force, as well as other College leaders, for their thoughts on what it will take to navigate this crisis. Specifically, we take a deeper look at the Task ...

The following are key points to remember from a 2023 ACC Expert Consensus Decision Pathway on management of heart failure with preserved ejection fraction (HFpEF): Heart failure with preserved ...

Contact: Olivia Walther, [email protected], WASHINGTON (Dec 11, 2023) - A world without cardiovascular disease (CVD) is possible, yet millions of lives are lost prematurely to heart disease each year, ...

Lipoprotein (a) (Lp [a]) is a low-density lipoprotein–like molecule with an apolipoprotein (b) moiety that is covalently attached to apolipoprotein (a) (Apo [a]), a plasminogen-like protein that ...

The replacement of regular salt with a salt substitute can reduce incidences of hypertension, or high blood pressure, in older adults without increasing their risk of low blood pressure episodes, ...

Influenza places a significant health burden on the US population, resulting in an estimated 140,000-810,000 hospitalizations and 12,000-61,000 deaths annually. 1 Influenza is associated with acute ...

A reduction in cardiovascular events and deaths among patients taking the prescription fish oil icosapent ethyl may be associated with higher blood levels of the omega-3 fatty acid eicosapentaenoic ...

New US Population Study Projects Steep Rise in Cardiovascular Diseases by 2060 CV rates are expected to significantly increase among minorities while decreasing among ...

Low-density lipoprotein-cholesterol (LDL-C) remains of utmost clinical importance; it is positioned in clinical trials as a treatment target and is emphasized in worldwide guidelines as the primary ...